Article Details
Retrieved on: 2021-02-24 16:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In August 2019, Alexion Pharmaceuticals, Inc, received extended marketing authorization approval from the European Commission (EC) for Soliris ...
Article found on: ksusentinel.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here